Homepage





-
About Us
Bakar Bio Labs is a world-class incubator for life-science startups. Now open to teams from around the world so anyone can leverage all that UC Berkeley offers.
Learn more -
Companies
Get to know our tenants, the hardworking innovators at the core of our community.
Learn more -
Facility
We enable bio startups to hit the ground running and focus on advancing their technology.
Learn more -
Resources
At Bakar Bio Labs, we connect you to sophisticated resources from UC Berkeley and the Bay Area, tailored to early-stage entrepreneurs.
Learn more -
Campus Programs
We’re a gateway to the biotech world for top academic talent at UC Berkeley.
Campus Programs


Marco Lobba and Sophia Lugo Named to San Francisco Business Times 40 Under 40
Learn more



Everything that a bio-entrepreneur needs, all in one location.
There has never been a shortage of entrepreneurs with great ideas designed to tackle the most pressing global challenges — from human health to environmental sustainability. But to grow those ideas into successful ventures, entrepreneurs need space, equipment, and multiple connections to a vibrant ecosystem. That’s why we created Bakar Bio Labs at UC Berkeley. Bakar Bio Labs is built to be the foundational hub for resources where startups thrive.

News & Events

Valitor Presents Multiple Preclinical Datasets on the Potential of its Innovative Anti-VEGF Therapy
“VLTR-559 was developed using our pioneering MVP technology platform and was designed to be an anti-VEGF therapy with increased potency and extended therapeutic duration compared to the current standard-of-care anti-VEGF biologics,” said Wesley Jackson, Ph.D., president and chief scientific officer of Valitor. “Based on our clinical modeling from preclinical results, we anticipate VLTR-559 could enable a twice-yearly dosing regimen for patients with wet AMD, thereby improving long-term outcomes while also reducing the clinical costs required to treat this disease. We are making great progress through IND-enabling activities with the goal of initiating a Phase 1 clinical study next year. Additionally, we are excited by the broader potential of our MVP platform, which is based on our proprietary methods of combining large molecular weight hyaluronic acid biopolymers with diverse active pharmaceutical ingredients to create potent and long-acting drugs.” Read post
Verinomics and Pinnacle Seed Form Strategic Partnership to Accelerate Innovation in Leafy Greens
Verinomics, a leader in agricultural genomics and gene editing, and Pinnacle Seed, a premier supplier of elite leafy green varieties, today announced a strategic partnership to combine top-tier genetics with cutting-edge breeding and gene editing technologies. The 5-year collaboration aims to develop next-generation leafy green varieties with enhanced disease resistance, improved yield, and superior agronomic profiles to address critical challenges facing growers and the entire supply chain. Read post
Keylika Develops World’s First Buccal Patch for Iron Deficiency Anemia
“Most people have no idea how debilitating iron deficiency anemia can be. As a critical micronutrient, iron has a foundational role to play in multiple biological processes in the body down to the cellular level, its uncorrected deficiency has far-reaching consequences,” says Buddha Chaudhuri, Ph.D., CEO of Biotech company, Keylika. After years working on drug delivery and medical devices, Keylika’s team has pioneered what could be a breakthrough solution: the world’s first buccal (oral) patch for treating iron deficiency. Read post
Ray Therapeutics Awarded $8M CIRM Grant to Advance RTx-015 Gene Therapy for Retinitis Pigmentosa
“Retinitis pigmentosa remains a devastating condition with no approved treatments for the vast majority of patients,” said Paul Bresge, CEO & Co-Founder, Ray Therapeutics. “We are deeply grateful to CIRM for their belief in our science and their continued support of our programs. We are honored to partner with CIRM as we advance therapies that have the potential to transform the lives of patients.” Read post
Bootstrapped Indian Startup Innovating Treatment for Eczema, Itch & Beyond
When personal health challenges inspire innovation, remarkable solutions can emerge. Such is the story behind NistuHeal, a breakthrough dermocosmetic product addressing eczema and chronic itch. After suffering from relentless eczema for a decade, Buddhadev “Buddha” Chaudhuri, Ph.D. and CEO of Keylika, turned his scientific expertise toward creating a better treatment. What began as a kitchen experiment has evolved into a successful family-run enterprise delivering relief to thousands across India. Read post
The Bay Area startup behind Shark Tank’s seaweed-based bacon
Seaweed might not be the first thing you think of sidling up on a plate with fried eggs and hash browns. But it’s high in protein, one of the fastest growing plants on earth, and requires no land, fresh water, or fertilizer. Read post
Fortune: Biotech startup Profluent says it has discovered AI ‘scaling laws’ for AI models used in protein design
Profluent, a biotechnology company that is using AI to design proteins, says it has demonstrated “scaling laws” in the performance of AI models for biology that are similar to those AI researchers have previously claimed for AI models built to handle language. Read post
Seeing the Tumors Again: How Vivere Oncotherapies is Unmasking Cancer
“One of the ways tumors grow within the body is that they can hide from the immune system, says Melissa Kotterman, CEO of Bakar Bio Labs’ newest tenant, Vivere Oncotherapies. “Our technology helps the immune system see the tumors again. We can wake up the immune system and say, ‘Hey, there’s a tumor over here, you can come get it.’” Vivere is engineering a platform to carry and improve the performance of oncolytic viruses that invade and replicate within the cancer cells, signalling the immune system to attack the tumor. Co-founders Hyuncheol Lee and Adam Schieferecke have shown that the engineering platform can be used to improve distribution through the tumor, decrease the tumor size, and increase survival compared to a non-engineered version in a mouse model of colorectal cancer. Read post
Health care, biotech startups chase AI ‘superpowers’
Health care and biotech startups are chasing the potential “superpowers” of artificial intelligence for applications as varied as novel protein development, clinical trials and patient records. Read postOur affiliates

Ready to run?
Startups need to focus on making milestones, not managing equipment.
Bakar Bio Labs maintains tissue culture facilities, a freezer farm, fume hoods, basic benchtop equipment and plenty of analytical instruments. Optional lab support services can also make for quick starts that help get results fast.




At UC Berkeley
Bakar Bio Labs is just steps from UC Berkeley’s world-renowned faculty and more than 40,000 students who train in top programs including science, engineering, law and business. Dotting the campus is a network of core facilities that feature a wide range of advanced equipment and services for use by startups. Recruiting student talent and scientific co-founders couldn’t be easier.
Scale means community

Today’s best startups blaze a trail all their own, but they don’t do it alone.
They build their support network to help them navigate the multiple challenges they face. At Bakar Bio Labs, tenants join a community of as many as 50 like-minded teams willing to share the scientific and business insights that help them advance. The incubator spans more than 40,000 square feet of lab and office spaces within the fully renovated Woo Hon Fai Hall, the iconic former home of the Berkeley Art Museum. With so much going on, investors, industry partners and new talent are already taking notice.
Bringing the innovation community together.
Funding raised to date
Bakar Bio Labs gives startups great exposure to savvy, motivated investors and industry business development.
Tenant and alumni companies
We welcome companies from all sectors of life science who have a need for specialized wet lab operations.
Affiliations
We’re building a mutually beneficial ecosystem that brings startups together with biotech, pharma, VC, law firms and banking.
Built for startups. For more than 20 years, QB3 has been the University of California’s center for innovation and entrepreneurship in life science. Through pitch summits, seminars, symposia, podcasts, office hours, internships, and workshops QB3 educates, connects, and elevates the entrepreneurial ecosystem.
